After nearly a decade in the role, Agilent Technologies CEO Mike McMullen is stepping down. McMullen, who’s also currently ...
AbbVie is wrapping its tentacles around a few more oncology and immunology candidates thanks to a new $64 million deal with ...
Bavarian Nordic may be celebrating its most profitable year yet on the back of mpox vaccine sales, but that hasn’t stopped ...
The pace of clinical trial starts is leveling out, dropping below pre-pandemic highs with a 15% decline in 2023 compared to the year before. A third (32%) of the overall clinical trial slowdown is due ...
When he sat down with Fierce Biotech back in August 2022, David Fredrickson made no secret of the fact that AstraZeneca’s ...
U.S.- and Australia-based CRO Avance Clinical has inked a deal with Ryght to use the generative artificial intelligence ...
Worldwide Clinical Trials has completed an expansion of the pharmacy at its clinical pharmacology unit (CPU) in San Antonio.
In much the same way that Cagent Vascular’s flagship device is designed to help open up blocked arteries to promote blood ...
A tiny surgical robot has picked up a large sum: Medical Microinstruments has secured $110 million in venture capital funding ...
NodThera’s lead clinical-stage drug for Parkinson’s disease is almost as effective at inducing weight loss as Novo Nordisk’s ...
Doron Tavlin, formerly Mazor’s VP of business development, was found guilty by a federal jury this month on several charges ...
Rapt Therapeutics is reeling from an “unfortunate and unexpected” clinical hold after a patient in a phase 2 immunology trial ...